Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
79
CNM Quote, Financials, Valuation and Earnings
Last price:
$61.85
Seasonality move
:
-4.87%
Day range:
$60.41 - $61.94
52-week range:
$37.22 - $63.25
Dividend yield:
0%
P/E ratio:
28.77x
P/S ratio:
1.63x
P/B ratio:
6.73x
Volume:
2.2M
Avg. volume:
2.2M
1-year change:
21.01%
Market cap:
$11.7B
Revenue:
$7.4B
EPS (TTM):
$2.15
Earnings Data
Next earnings date for CNM
Sep 04
2025
Most recent earnings per share
$0.52
Missed by $0.02
(Jun 10/2025)
Consensus Estimate
$0.54
(Jun 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CNM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/04/2025 | Q3 | $2.1B | -- | -- | $0.79 | -- |
| 06/10/2025 | Q2 | $1.8B | $1.9B | $0.52 | $0.54 | -$0.02 |
| 03/25/2025 | Q1 | $1.7B | $1.7B | $0.33 | $0.36 | -$0.03 |
| 12/03/2024 | Q4 | $2B | $2B | $0.69 | $0.66 | $0.03 |
| 09/04/2024 | Q3 | $2.1B | $2B | $0.61 | $0.74 | -$0.13 |
| 06/04/2024 | Q2 | $1.7B | $1.7B | $0.49 | $0.52 | -$0.03 |
| 03/19/2024 | Q1 | $1.4B | $1.4B | $0.34 | $0.34 | -$0.00 |
| 12/05/2023 | Q4 | $1.8B | $1.8B | $0.65 | $0.67 | -$0.02 |
| 09/06/2023 | Q3 | $1.9B | $1.9B | $0.66 | $0.67 | -$0.01 |
| 06/06/2023 | Q2 | -- | $1.6B | $0.50 | -- | -- |
| 03/28/2023 | Q1 | -- | $1.4B | $0.31 | -- | -- |
| 12/13/2022 | Q4 | -- | $1.8B | $0.65 | -- | -- |
| 09/13/2022 | Q3 | -- | $1.9B | $0.67 | -- | -- |
| 06/14/2022 | Q2 | -- | $1.6B | $0.50 | -- | -- |
| 03/30/2022 | Q1 | -- | $1.2B | $0.28 | -- | -- |
| 12/07/2021 | Q4 | -- | $1.4B | $0.39 | -- | -- |
| 09/14/2021 | Q3 | -- | $1.3B | -$0.14 | -- | -- |
| 04/30/2021 | Q2 | -- | $1.1B | $0.11 | -- | -- |
| 01/31/2021 | Q1 | -- | $831.5M | $0.00 | -- | -- |
| 10/31/2020 | Q4 | -- | $1B | $0.09 | -- | -- |
| 07/31/2020 | Q3 | -- | $955.9M | $0.08 | -- | -- |
| 04/30/2020 | Q2 | -- | $842.1M | -$0.02 | -- | -- |
Core & Main Earnings Questions
-
How Much did Core & Main Generate in Revenue Last Quarter?
Core & Main reported $1.9B worth of top line sales in its most recent quarter.
-
Did Core & Main Beat Earnings Last Quarter?
Core & Main announced earnings per share of $0.52 which represents a miss of analyst forecast a $0.54 per share.
-
Is Core & Main Profitable?
Core & Main reported $510M that represents $2.57 per share over the last quarter.
-
What is the Analyst Consensus for Core & Main EPS Next Year?
Core & Main's earnings are forecast to grow from $2.13 per share to $2.21 per share next year representing an increase of 17.36%.
-
When is Core & Main's Earnings Date?
Core & Main's next earnings date is September 4, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 1.01% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 10.79% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 5.29% over the past day.
